Literature DB >> 35966717

Nanotheranostics and its role in diagnosis, treatment and prevention of COVID-19.

Lipsa Leena Panigrahi1, Banishree Sahoo1, Manoranjan Arakha1.   

Abstract

Microbe-related, especially viral-related pandemics have currently paralyzed the world and such pathogenesis is expected to rise in the upcoming years. Although tremendous efforts are being made to develop antiviral drugs, very limited progress has been made in this direction. The nanotheranostic approach can be a highly potential rescue to combat this pandemic. Nanoparticles (NPs) due to their high specificity and biofunctionalization ability could be utilized efficiently for prophylaxis, diagnosis and treatment against microbial infections. In this context, titanium oxide, silver, gold NPs, etc. have already been utilized against deadly viruses like influenza, Ebola, HIV, and HBV. The discovery of sophisticated nanovaccines is under investigation and of prime importance to induce reproducible and strong immune responses against difficult pathogens. This review focuses on highlighting the role of various nano-domain materials such as metallic NPs, magnetic NPs, and quantum dots in the biomedical applications to combat the deadly microbial infections. Further, it also discusses the nanovaccines those are already available for various microbial diseases or are in clinical trials. Finally, it gives a perspective on the various nanotechnologies presently employed for efficient diagnosis and therapy against disease causing microbial infections, and how advancement in this field can benefit the health sector remarkably. © Higher Education Press 2022.

Entities:  

Keywords:  SARS-CoV-2; antimicrobial; antiviral; nanotheranostics; nanovaccine

Year:  2022        PMID: 35966717      PMCID: PMC9362558          DOI: 10.1007/s11706-022-0611-y

Source DB:  PubMed          Journal:  Front Mater Sci            Impact factor:   2.612


  61 in total

Review 1.  Nanotechnology-based drug delivery systems for control of microbial biofilms: a review.

Authors:  Matheus Aparecido Dos Santos Ramos; Patrícia Bento Da Silva; Larissa Spósito; Luciani Gaspar De Toledo; Bruna Vidal Bonifácio; Camila Fernanda Rodero; Karen Cristina Dos Santos; Marlus Chorilli; Taís Maria Bauab
Journal:  Int J Nanomedicine       Date:  2018-02-27

Review 2.  Nanotechnology approaches for global infectious diseases.

Authors:  Ameya R Kirtane; Malvika Verma; Paramesh Karandikar; Jennifer Furin; Robert Langer; Giovanni Traverso
Journal:  Nat Nanotechnol       Date:  2021-03-22       Impact factor: 39.213

3.  A nanosensor for transmembrane capture and identification of single nucleic Acid molecules.

Authors:  Jonathan Nakane; Matthew Wiggin; Andre Marziali
Journal:  Biophys J       Date:  2004-07       Impact factor: 4.033

4.  Solid lipid nanoparticles: a modern formulation approach in drug delivery system.

Authors:  S Mukherjee; S Ray; R S Thakur
Journal:  Indian J Pharm Sci       Date:  2009-07       Impact factor: 0.975

5.  The effects of interfacial potential on antimicrobial propensity of ZnO nanoparticle.

Authors:  Manoranjan Arakha; Mohammed Saleem; Bairagi C Mallick; Suman Jha
Journal:  Sci Rep       Date:  2015-04-15       Impact factor: 4.379

Review 6.  Nanotheranostics - application and further development of nanomedicine strategies for advanced theranostics.

Authors:  Madaswamy S Muthu; David Tai Leong; Lin Mei; Si-Shen Feng
Journal:  Theranostics       Date:  2014-03-26       Impact factor: 11.556

Review 7.  Surface Modified Multifunctional and Stimuli Responsive Nanoparticles for Drug Targeting: Current Status and Uses.

Authors:  Panoraia I Siafaka; Neslihan Üstündağ Okur; Evangelos Karavas; Dimitrios N Bikiaris
Journal:  Int J Mol Sci       Date:  2016-08-31       Impact factor: 5.923

8.  DNA origami single crystals with Wulff shapes.

Authors:  Yong Wang; Lizhi Dai; Zhiyuan Ding; Min Ji; Jiliang Liu; Hang Xing; Xiaoguo Liu; Yonggang Ke; Chunhai Fan; Peng Wang; Ye Tian
Journal:  Nat Commun       Date:  2021-05-21       Impact factor: 14.919

Review 9.  Repurposed Drugs, Molecular Vaccines, Immune-Modulators, and Nanotherapeutics to Treat and Prevent COVID-19 Associated with SARS-CoV-2, a Deadly Nanovector.

Authors:  Taru Dube; Amrito Ghosh; Jibanananda Mishra; Uday B Kompella; Jiban Jyoti Panda
Journal:  Adv Ther (Weinh)       Date:  2020-10-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.